Shine-On BioMedical Co.,Ltd.
Taipei Exchange 6926.TWO
Shine-On BioMedical Co.,Ltd. Market Capitalization on January 14, 2025: USD 99.54 M
Shine-On BioMedical Co.,Ltd. Market Capitalization is USD 99.54 M on January 14, 2025, a 5.40% change year over year. Market capitalization represents total company value in stock market; higher suggests larger, more established company.
-
Shine-On BioMedical Co.,Ltd. 52-week high Market Capitalization is USD 105.34 M on October 30, 2024, which is 5.82% above the current Market Capitalization.
-
Shine-On BioMedical Co.,Ltd. 52-week low Market Capitalization is USD 87.35 M on August 06, 2024, which is -12.25% below the current Market Capitalization.
-
Shine-On BioMedical Co.,Ltd. average Market Capitalization for the last 52 weeks is USD 96.20 M.
Key data
| Date | Market Capitalization | Share Price | Price to Earnings Ratio (P/E) | Price to Sales Ratio (P/S) |
|---|
Market news
Loading...
Taipei Exchange: 6926.TWO
| CEO | Mr. Hongzhe Jiang |
| IPO Date | Nov. 25, 2022 |
| Location | |
| Headquarters | No. 633, Taiwan Avenue |
| Employees | 19 |
| Sector | Health Care |
| Industries | |
Description
Shine-On BioMedical Co.,Ltd. research, develops, and manufactures anti-cancer related drug products. It also develops antibody anticancer drugs, such as exosome anti-cancer drugs, that includes SOB101 and SOB102; SOB201 for engineered multi-target exosomes; SOA101, a dual immune checkpoint T cell adapter antibody; and SOA201, a trispecific adapter immune cell antibody. The company was founded in 2021 and is based in Taichung, Taiwan.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email